


The Invesco Perpetual Distribution Fund aims to achieve a balance of income and capital growth through a portfolio of primarily UK equity and fixed interest securities.
| Name | % Net Assets | 
|---|---|
| AstraZeneca | 2.8% | 
| GlaxoSmithKline | 2.8% | 
| British American Tobacco | 2.0% | 
| BP | 1.9% | 
| Vodafone | 1.9% | 
| BG | 1.8% | 
| Reynolds American | 1.7% | 
| Imperial Tobacco | 1.6% | 
| National Grid | 1.6% | 
| Tesco | 1.5% | 
| Key | % Net Assets | 
|---|---|
| 2.8% | |
| 2.8% | |
| 2.0% | |
| 1.9% | |
| 90.5% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 61.29p | 
| Currency | GBP | 
| Change | 0.080p | 
| % | 0.13% | 
| YTD change | 2.02p | 
| YTD % | 3.41% | 
| Fund Inception | 26/01/2004 | 
|---|---|
| Fund Manager | Paul Causer / Paul Read | 
| TER | 1.57 (31-Dec-2013) | 
| Minimum Investment | |
|---|---|
| Initial | £500 | 
| Additional | £100 | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.54% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.00 | 
| Sharpe ratio | 0.30 | 
You are here: research